Riskpilot← Back to searchSign inGet full accessBEVITAL AS
ASActiveOrg 985694931Minde Allé 35, 5068 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200310 employeeswww.bevital.no
Revenue 2024
NOK 13,6M
+11% vs 2023
EBITDA margin
2.0%
+113% vs 2023
Equity ratio
-15.7%
Financial strength
Net profit 2024
NOK -1,1M
+55% vs 2023
| Revenue | NOK 13,6M | +11% |
| EBITDA | NOK 273K | +113% |
| Net profit | NOK -1,1M | +55% |
| Total assets | NOK 16,8M | +111% |
| Equity | NOK -2,6M | -71% |
| Employees | 10 | — |
Legal name
BEVITAL AS
Org number
985694931
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21. mai 2003
Share capital
NOK 1 000 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg eller to styremedlemmer i fellesskap eller ett styremedlem og ett varamedlem i fellseskap.
Company purpose
Forskning og utviklingsarbeid innen naturvitenskap og teknikk. Herunder kommersiell utnyttelse av forskningsresultater samt investering og deltakelse i andre virksomheter.
Address
Minde Allé 35, 5068 Bergen
Phone
+4755974694
Email
post@bevital.no
Website
www.bevital.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 524 | 7 329 | 10 554 | 12 262 | 13 618 |
| Staff expenses | −8 221 | −8 968 | −9 361 | −9 830 | −8 514 |
| EBITDA | 2 056 | −5 649 | −1 921 | −2 177 | 273 |
| Depreciation & amort. | −679 | −452 | −239 | −356 | −1 392 |
| EBIT | 1 377 | −6 100 | −2 160 | −2 533 | −1 119 |
| Net financials | −1 415 | −722 | −237 | 115 | 28 |
| Profit before tax | −38 | −6 823 | −2 397 | −2 418 | −1 091 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −38 | −6 823 | −2 397 | −2 418 | −1 091 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 207 | 5 627 | 7 357 | 7 946 | 16 765 |
| Equity | −40 856 | −47 678 | 883 | −1 536 | −2 627 |
| Long-term debt | 46 199 | 48 877 | 1 260 | 2 335 | 11 637 |
| Short-term debt | 2 864 | 4 429 | 5 214 | 7 146 | 7 755 |
| Total debt | 49 062 | 53 305 | 6 474 | 9 481 | 19 392 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
-15.7%
This company
38.2%
Market median
-141% vs market
20202024
Return on equity
-109113000.0%
This company
18.4%
Market median
-593005535% vs market
20202024
Net profit margin
-8.0%
This company
8.1%
Market median
-199% vs market
20202024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20202024
Debt / equity
7.38×
This company
0.62×
Market median
-1090% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ON Deputy Member | Deputy Member | 2022 |
RM Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
RM Deputy Member | Deputy Member | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Chairman | 2022 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stiftelsen For Å Fremme Forskning Innen Funksjonell Vitamin B 12-Mangel
BEVITAL AS Board members of BEVITAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Magne Husebø | Deputy Member | 0 companies |
| Ove Netland | Deputy Member | 0 companies |
| Randi Mjelde Heimdal | Chief Executive Officer | 0 companies |
| Ove Årseth | Board of Directors | 0 companies |
| Per Christian Eriksen | Chairman | 0 companies |
| Adrian Philip Mccann | Board of Directors | 0 companies |
| Jørn Schneede | Deputy Chairman | 0 companies |
| Per Magne Ueland | Board of Directors | 0 companies |
| Klaus Arnold Heinrich Meyer | Board of Directors | 0 companies |